CTRX Related Analyst Ratings
-
ISI Group Downgrades Catamaran (CTRX) to Buy
-
Catamaran (CTRX) Has Room to Run, Thinks Analyst
-
Sell Catamaran (CTRX) Ahead of HealthSpring Contract Update - Cramer
-
Morgan Stanley Upgrades Catamaran (CTRX) to Overweight
-
Buckle-Up Ahead of Elections as Health Care Stocks Take a Ride
-
Goldman Sachs Downgrades Watson Pharmaceuticals (WPI) to Buy
-
Goldman Sachs Upgrades Catamaran (CTRX) to Conviction Buy
-
JMP Resumes PBM Providers: CVS, MCK, ESRX at Outperform, CTRX at Market Perform
-
Jefferies Reiterates a 'Buy' on Catamaran (CTRX); Compelling Opportunity
-
ISI Group Starts Catamaran (CTRX) at Overweight
-
Goldman Sachs Names iPad Winners and Losers (AAPL, ARMH, MSFT, more...)
-
UBS upgrades Cotherix (CTRX) to Buy
-
UBS Starts CTRX at Neutral
-
Leerink Swann Starts CTRX at Outperform
-
Piper Jaffray Starts FFIV and RDWR at Market Perform
-
Needham starts CTRX at Buy
-
Thomas Weisel Partners Started CTRX at Outperform; $11 trgt
Back to CTRX Stock Lookup
